Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,399 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Citius Pharmaceuticals Inc | CTXR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0027 | 0.35% | 0.77 | 06:16:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7673 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 1,399 | - | 0.60 - 1.6189 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:17:51 | formt | 999 | $ 0.77 | USD |
Citius Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 122.5M | 159.09M | - | 0 | -33.69M | -0.21 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Citius Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTXR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7501 | 1.04 | 0.70 | 0.7870666 | 2,144,929 | 0.0199 | 2.65% |
| 1 Month | 0.79 | 1.07 | 0.70 | 0.8599821 | 1,280,221 | -0.02 | -2.53% |
| 3 Months | 0.628 | 1.07 | 0.60 | 0.7943033 | 840,401 | 0.142 | 22.61% |
| 6 Months | 0.6149 | 1.07 | 0.60 | 0.7781317 | 719,828 | 0.1551 | 25.22% |
| 1 Year | 1.58 | 1.6189 | 0.60 | 1.01 | 1,064,685 | -0.81 | -51.27% |
| 3 Years | 1.7922 | 4.56 | 0.60 | 1.96 | 1,990,194 | -1.02 | -57.04% |
| 5 Years | 1.05 | 4.56 | 0.40 | 1.84 | 2,361,050 | -0.28 | -26.67% |
Citius Pharmaceuticals Description
| Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome. |
